These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 2408729

  • 1. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
    Gupta MK, Arciaga R, Bocci L, Tubbs R, Bukowski R, Deodhar SD.
    Cancer; 1985 Jul 15; 56(2):277-83. PubMed ID: 2408729
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].
    Deguchi H, Tabuchi Y, Saitoh Y.
    Nihon Geka Gakkai Zasshi; 1988 May 15; 89(5):671-83. PubMed ID: 3166103
    [Abstract] [Full Text] [Related]

  • 6. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
    Pant KD, Shochat D, Nelson MO, Goldenberg DM.
    Cancer; 1982 Sep 01; 50(5):919-26. PubMed ID: 6178498
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
    Ohuchi N, Takahashi K, Matoba N, Sato T, Taira Y, Sakai N, Masuda M, Mori S.
    Jpn J Clin Oncol; 1989 Sep 01; 19(3):242-8. PubMed ID: 2810823
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumor markers carcinoembryonic antigen, tissue polypeptide antigen, and carbohydrate antigen 19/9 in liver diseases.
    Putzki H, Ledwoch J, Student A, Jablonski M, Heymann H.
    J Surg Oncol; 1988 Feb 01; 37(2):133-5. PubMed ID: 3278167
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
    Quentmeier A, Schlag P, Geisen HP, Schmidt-Gayk H.
    Eur J Surg Oncol; 1987 Jun 01; 13(3):197-201. PubMed ID: 3474158
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Studies on serum CEA levels measured by enzyme immunoassay using monoclonal CEA-antibodies].
    Takada S, Hoshi H, Ito F, Imai K, Yachi A.
    Gan To Kagaku Ryoho; 1984 Jul 01; 11(7):1487-91. PubMed ID: 6378102
    [Abstract] [Full Text] [Related]

  • 18. Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank.
    Ritts RE, Del Villano BC, Go VL, Herberman RB, Klug TL, Zurawski VR.
    Int J Cancer; 1984 Mar 15; 33(3):339-45. PubMed ID: 6199316
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.